G. Mills and W. Moolenaar, The emerging role of lysophosphatidic acid in cancer, Nature Reviews Cancer, vol.3, issue.8, pp.582-91, 2003.
DOI : 10.1038/nrc1143

A. Boucharaba, C. Serre, and S. Gres, Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer, Journal of Clinical Investigation, vol.114, issue.12, pp.1714-1739, 2004.
DOI : 10.1172/JCI200422123
URL : https://hal.archives-ouvertes.fr/inserm-00110127

O. Peyruchaud, C. Serre, and R. Nicamhlaoibh, Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity, Journal of Biological Chemistry, vol.278, issue.46, pp.45826-45858, 2003.
DOI : 10.1074/jbc.M309024200

M. Umezu-goto, Y. Kishi, and A. Taira, Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production, The Journal of Cell Biology, vol.1, issue.2, pp.227-260, 2002.
DOI : 10.1016/S0960-9822(98)70157-5

T. Eichholtz, K. Jalink, I. Fahrenfort, and W. Moolenaar, The bioactive phospholipid lysophosphatidic acid is released from activated platelets, Biochemical Journal, vol.291, issue.3, pp.677-80, 1993.
DOI : 10.1042/bj2910677

G. Gasic, T. Gasic, and N. Galanti, Platelet???tumor-cell interactions in mice. The role of platelets in the spread of malignant disease, International Journal of Cancer, vol.20, issue.3, pp.704-722, 1973.
DOI : 10.1002/ijc.2910110322